Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy

被引:2
作者
Liu, Beibei [1 ,2 ]
Liu, Ling [3 ]
Liu, Yang [4 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Radiol, Funct & Mol Imaging Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Huaxi MR Res Ctr HMRRC, Chengdu, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp, Dept Gen Surg, Div Biliary Surg, Chengdu, Sichuan, Peoples R China
[4] Sichuan Univ, West China Hosp, Day Surg Ctr, Gen Practice Med Ctr, Chengdu, Sichuan, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词
autophagy; ferroptosis; cancer progression; drug resistance; cell death; tumor; SORAFENIB-INDUCED FERROPTOSIS; ENDOPLASMIC-RETICULUM STRESS; DOWN-REGULATION; DRUG-RESISTANCE; CANCER-CELL; INHIBITS AUTOPHAGY; SIGNALING PATHWAY; ACTIVATING AUTOPHAGY; LIPID-PEROXIDATION; METABOLIC STRESS;
D O I
10.3389/fimmu.2024.1450487
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ferroptosis is a type of cell death that plays a remarkable role in the growth and advancement of malignancies including hepatocellular carcinoma (HCC). Non-coding RNAs (ncRNAs) have a considerable impact on HCC by functioning as either oncogenes or suppressors. Recent research has demonstrated that non-coding RNAs (ncRNAs) have the ability to control ferroptosis in HCC cells, hence impacting the advancement of tumors and the resistance of these cells to drugs. Autophagy is a mechanism that is conserved throughout evolution and plays a role in maintaining balance in the body under normal settings. Nevertheless, the occurrence of dysregulation of autophagy is evident in the progression of various human disorders, specifically cancer. Autophagy plays dual roles in cancer, potentially influencing both cell survival and cell death. HCC is a prevalent kind of liver cancer, and genetic mutations and changes in molecular pathways might worsen its advancement. The role of autophagy in HCC is a subject of debate, as it has the capacity to both repress and promote tumor growth. Autophagy activation can impact apoptosis, control proliferation and glucose metabolism, and facilitate tumor spread through EMT. Inhibiting autophagy can hinder the growth and spread of HCC and enhance the ability of tumor cells to respond to treatment. Autophagy in HCC is regulated by several signaling pathways, such as STAT3, Wnt, miRNAs, lncRNAs, and circRNAs. Utilizing anticancer drugs to target autophagy may have advantageous implications for the efficacy of cancer treatment.
引用
收藏
页数:28
相关论文
共 337 条
  • [1] Deregulation of RB1 expression by loss of imprinting in human hepatocellular carcinoma
    Anwar, Sumadi Lukman
    Krech, Till
    Hasemeier, Britta
    Schipper, Elisa
    Schweitzer, Nora
    Vogel, Arndt
    Kreipe, Hans
    Lehmann, Ulrich
    [J]. JOURNAL OF PATHOLOGY, 2014, 233 (04) : 392 - 401
  • [2] Manipulation of autophagy in cancer cells: an innovative strategy to fight drug resistance
    Aredia, Francesca
    Scovassi, A. Ivana
    [J]. FUTURE MEDICINAL CHEMISTRY, 2013, 5 (09) : 1009 - 1021
  • [3] A bioinformatics analysis, pre-clinical and clinical conception of autophagy in pancreatic cancer: Complexity and simplicity in crosstalk
    Ashrafizadeh, Milad
    Zhang, Wei
    Zou, Rongjun
    Sethi, Gautam
    Klionsky, Daniel J.
    Zhang, Xianbin
    [J]. PHARMACOLOGICAL RESEARCH, 2023, 194
  • [4] Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response
    Ashrafizadeh, Milad
    Paskeh, Mahshid Deldar Abad
    Mirzaei, Sepideh
    Gholami, Mohammad Hossein
    Zarrabi, Ali
    Hashemi, Farid
    Hushmandi, Kiavash
    Hashemi, Mehrdad
    Nabavi, Noushin
    Crea, Francesco
    Ren, Jun
    Klionsky, Daniel J.
    Kumar, Alan Prem
    Wang, Yuzhuo
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [5] New Insight into Triple-Negative Breast Cancer Therapy: The Potential Roles of Endoplasmic Reticulum Stress and Autophagy Mechanisms
    Ashrafizadeh, Milad
    Mohammadinejad, Reza
    Tavakol, Shima
    Ahmadi, Zahra
    Sahebkar, Amirhossein
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2021, 21 (06) : 679 - 691
  • [6] MicroRNA-214-3p enhances erastin-induced ferroptosis by targeting ATF4 in hepatoma cells
    Bai, Tao
    Liang, Ruopeng
    Zhu, Rongtao
    Wang, Weijie
    Zhou, Lin
    Sun, Yuling
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (7-8) : 5637 - 5648
  • [7] Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells
    Bai, Tao
    Lei, Pengxu
    Zhou, Hao
    Liang, Ruopeng
    Zhu, Rongtao
    Wang, Weijie
    Zhou, Lin
    Sun, Yuling
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (11) : 7349 - 7359
  • [8] PIAS3 promotes ferroptosis by regulating TXNIP via TGF-β signaling pathway in hepatocellular carcinoma
    Bao, Wenfang
    Wang, Jialin
    Fan, Kailing
    Gao, Yong
    Chen, Jingde
    [J]. PHARMACOLOGICAL RESEARCH, 2023, 196
  • [9] MicroRNAs: Target Recognition and Regulatory Functions
    Bartel, David P.
    [J]. CELL, 2009, 136 (02) : 215 - 233
  • [10] PI3Kγ promotes obesity-associated hepatocellular carcinoma by regulating metabolism and inflammation
    Becattini, Barbara
    Breasson, Ludovic
    Sardi, Claudia
    Zani, Fabio
    Solinas, Giovanni
    [J]. JHEP REPORTS, 2021, 3 (06)